Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 946,000 | 1.0M | 973,000 | 1.4M | 1.3M |
| Operating Revenue | 946,000 | 1.0M | 973,000 | 1.4M | 1.3M |
| Cost Of Revenue | 304,000 | 353,000 | 36,000 | 361,000 | 400,000 |
| Gross Profit | 642,000 | 690,000 | 937,000 | 1.1M | 852,000 |
| Selling General And Administration | 501,000 | 492,000 | 551,000 | 651,000 | 726,000 |
| General And Administrative Expense | 501,000 | 492,000 | 551,000 | 651,000 | 726,000 |
| Other Operating Expenses | 759,000 | 383,000 | 814,000 | 678,000 | 634,000 |
| Operating Expense | 1.3M | 875,000 | 1.4M | 1.3M | 1.4M |
| Operating Income | -618,000 | -185,000 | -428,000 | -259,000 | -508,000 |
| EBIT | -633,000 | -206,000 | -3.0M | -284,000 | -570,000 |
| Interest Expense | 45,000 | 52,000 | 24,000 | 86,000 | 38,000 |
| Interest Expense Non Operating | 45,000 | 52,000 | 24,000 | 86,000 | 38,000 |
| Interest Income | -- | -- | -- | -- | 0.00 |
| Interest Income Non Operating | -- | -- | -- | -- | 0.00 |
| Net Interest Income | -45,000 | -52,000 | -24,000 | -86,000 | -38,000 |
| Other Income Expense | -15,000 | -21,000 | -2.5M | -25,000 | -62,000 |
| Special Income Charges | -- | -- | -2.5M | -73,000 | -- |
| Gain On Sale Of Security | -15,000 | -21,000 | -11,000 | 48,000 | -62,000 |
| Pretax Income | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Net Income From Continuing Operation Net Minority Interest | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Net Income Including Noncontrolling Interests | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Net Income Common Stockholders | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Net Income | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| EBITDA | -388,000 | 46,000 | -3.0M | -9,000 | -290,000 |
| Normalized EBITDA | -373,000 | 67,000 | -428,000 | 16,000 | -228,000 |
| Reconciled Depreciation | 245,000 | 252,000 | -53,000 | 275,000 | 280,000 |
| Basic EPS | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Diluted EPS | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Basic Average Shares | 485.3M | 485.3M | -- | 485.3M | 485.3M |
| Diluted Average Shares | 485.3M | 485.3M | -- | 485.3M | 485.3M |
| Total Unusual Items | -15,000 | -21,000 | -2.5M | -25,000 | -62,000 |
| Total Unusual Items Excluding Goodwill | -15,000 | -21,000 | -2.5M | -25,000 | -62,000 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -663,000 | -237,000 | -452,000 | -345,000 | -546,000 |
| Diluted NI Availto Com Stockholders | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Gain On Sale Of Ppe | -- | -- | 0.00 | -73,000 | -- |
| Net Income Continuous Operations | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Net Non Operating Interest Income Expense | -45,000 | -52,000 | -24,000 | -86,000 | -38,000 |
| Other Gand A | 497,000 | 487,000 | 546,000 | 644,000 | 725,000 |
| Reconciled Cost Of Revenue | 304,000 | 353,000 | 36,000 | 361,000 | 400,000 |
| Salaries And Wages | 4,000 | 5,000 | 5,000 | 7,000 | 1,000 |
| Total Expenses | 1.6M | 1.2M | 1.4M | 1.7M | 1.8M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 814,000 | 913,000 | 708,000 | 702,000 | 522,000 |
| Cash Cash Equivalents And Short Term Investments | 814,000 | 913,000 | 708,000 | 702,000 | 522,000 |
| Accounts Receivable | 1.7M | 1.6M | -- | 1.9M | 2.0M |
| Receivables | 1.7M | 1.6M | 1.7M | 1.9M | 2.0M |
| Prepaid Assets | 868,000 | 902,000 | 980,000 | 741,000 | 826,000 |
| Current Assets | 3.4M | 3.4M | 3.4M | 3.3M | 3.3M |
| Gross PPE | 65.8M | 63.4M | 63.8M | 66.4M | 70.9M |
| Accumulated Depreciation | -38.4M | -36.6M | -36.6M | -36.2M | -38.7M |
| Net PPE | 27.4M | 26.8M | 27.3M | 30.2M | 32.2M |
| Total Non Current Assets | 27.4M | 26.8M | 27.3M | 30.2M | 32.2M |
| Total Assets | 30.8M | 30.2M | 30.6M | 33.6M | 35.5M |
| Current Debt | -- | -- | -- | 969,000 | -- |
| Current Debt And Capital Lease Obligation | -- | -- | -- | 969,000 | -- |
| Accounts Payable | 2.1M | 1.8M | 1.8M | 1.4M | 3.2M |
| Payables | 2.1M | 1.8M | 1.8M | 1.4M | 3.2M |
| Payables And Accrued Expenses | 2.1M | 1.8M | 1.8M | 1.4M | 3.2M |
| Current Liabilities | 2.1M | 1.8M | 1.8M | 2.4M | 3.2M |
| Long Term Debt | 1.7M | 1.7M | 1.7M | 704,000 | -- |
| Long Term Debt And Capital Lease Obligation | 1.7M | 1.7M | 1.7M | 704,000 | -- |
| Total Non Current Liabilities Net Minority Interest | 4.9M | 4.8M | 4.8M | 4.3M | 3.8M |
| Total Liabilities Net Minority Interest | 7.1M | 6.6M | 6.6M | 6.7M | 6.9M |
| Common Stock | 118.8M | 118.8M | 118.8M | 118.8M | 118.8M |
| Capital Stock | 118.8M | 118.8M | 118.8M | 118.8M | 118.8M |
| Additional Paid In Capital | 8.2M | 8.2M | 8.2M | 8.1M | 8.1M |
| Retained Earnings | -101.0M | -100.3M | -100.0M | -97.0M | -96.7M |
| Gains Losses Not Affecting Retained Earnings | -2.3M | -3.0M | -2.9M | -3.1M | -1.7M |
| Common Stock Equity | 23.7M | 23.7M | 24.0M | 26.9M | 28.6M |
| Stockholders Equity | 23.7M | 23.7M | 24.0M | 26.9M | 28.6M |
| Total Equity Gross Minority Interest | 23.7M | 23.7M | 24.0M | 26.9M | 28.6M |
| Total Capitalization | 25.4M | 25.4M | 25.7M | 27.6M | 28.6M |
| Net Tangible Assets | 23.7M | 23.7M | 24.0M | 26.9M | 28.6M |
| Tangible Book Value | 23.7M | 23.7M | 24.0M | 26.9M | 28.6M |
| Working Capital | 1.3M | 1.7M | 1.6M | 957,000 | 152,000 |
| Invested Capital | 25.4M | 25.4M | 25.7M | 28.5M | 28.6M |
| Total Debt | 1.7M | 1.7M | 1.7M | 1.7M | -- |
| Net Debt | 886,000 | 787,000 | 992,000 | 971,000 | -- |
| Share Issued | 485.3M | 485.3M | 485.3M | 485.3M | 485.3M |
| Ordinary Shares Number | 485.3M | 485.3M | 485.3M | 485.3M | 485.3M |
| Duefrom Related Parties Current | -- | -- | 1.7M | -- | -- |
| Long Term Provisions | 3.2M | 3.1M | 3.1M | 3.6M | 3.8M |
| Other Current Borrowings | -- | -- | -- | 969,000 | -- |
| Other Properties | 490,000 | 490,000 | 490,000 | 490,000 | 490,000 |
| Other Receivables | -- | -- | 6,000 | -- | -- |
| Properties | 65.3M | 62.9M | 63.3M | 65.9M | 70.4M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -520,000 | 281,000 | -270,000 | 298,000 | -129,000 |
| Cash Flow From Continuing Operating Activities | -520,000 | 281,000 | -270,000 | 298,000 | -129,000 |
| Depreciation And Amortization | -- | 1,000 | 0.00 | -- | -- |
| Depreciation Amortization Depletion | 245,000 | 252,000 | -53,000 | 275,000 | 280,000 |
| Stock Based Compensation | 4,000 | 5,000 | 5,000 | 7,000 | 1,000 |
| Change In Working Capital | -118,000 | 258,000 | 232,000 | 275,000 | 165,000 |
| Other Non Cash Items | 31,000 | 31,000 | 39,000 | 39,000 | 37,000 |
| Capital Expenditure | -56,000 | -- | -- | -12,000 | -9,000 |
| Purchase Of PPE | -- | -- | -- | -- | -- |
| Net PPE Purchase And Sale | 0.00 | 60,000 | 0.00 | 110,000 | 0.00 |
| Investing Cash Flow | 398,000 | -68,000 | 1.8M | -1.8M | 83,000 |
| Cash Flow From Continuing Investing Activities | 398,000 | -68,000 | 1.8M | -1.8M | 83,000 |
| Repayment Of Debt | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -- | -- | 1.7M | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | -2,000 | -1.6M | 1.7M | 0.00 |
| Cash Flow From Continuing Financing Activities | 0.00 | -2,000 | -1.6M | 1.7M | 0.00 |
| Effect Of Exchange Rate Changes | 23,000 | -6,000 | 4,000 | -25,000 | 11,000 |
| Changes In Cash | -122,000 | 211,000 | 2,000 | 205,000 | -46,000 |
| Beginning Cash Position | 913,000 | 708,000 | 702,000 | 522,000 | 557,000 |
| End Cash Position | 814,000 | 913,000 | 708,000 | 702,000 | 522,000 |
| Free Cash Flow | -576,000 | 281,000 | -270,000 | 286,000 | -138,000 |
| Interest Paid Supplemental Data | 45,000 | -- | 45,000 | 66,000 | 1,000 |
| Capital Expenditure Reported | -56,000 | 0.00 | 0.00 | -12,000 | -9,000 |
| Depletion | -- | 251,000 | -53,000 | -- | -- |
| Depreciation | -- | 1,000 | 0.00 | -- | -- |
| Gain Loss On Sale Of PPE | -- | -- | 0.00 | 73,000 | -- |
| Long Term Debt Payments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Foreign Currency Exchange Gain Loss | -4,000 | -7,000 | -30,000 | -1,000 | -4,000 |
| Net Income From Continuing Operations | -678,000 | -258,000 | -3.0M | -370,000 | -608,000 |
| Net Intangibles Purchase And Sale | -- | -- | 133,000 | 0.00 | -- |
| Net Long Term Debt Issuance | -- | -- | 1.7M | 0.00 | 0.00 |
| Net Other Financing Charges | -- | -2,000 | -3.3M | 1.7M | -- |
| Net Other Investing Changes | 454,000 | -128,000 | 1.7M | -1.9M | 92,000 |
| Operating Gains Losses | -4,000 | -7,000 | -30,000 | 72,000 | -4,000 |
| Sale Of Intangibles | -- | -- | 133,000 | 0.00 | -- |
| Sale Of PPE | 0.00 | 60,000 | 0.00 | 110,000 | 0.00 |